Rabbit-anti-MYRF polyclonal antibody
Catalog No: OB-PRB007
Host Species: Rabbit polyclonal antibodies
Important Notice: Antigen retrieval is required before IHC/IF staining.
Gene Synonyms: MRF, Gm98, myelin regulatory factor
Species Reactivity: Mouse, Rat, Human, Chicken; Other species have not been tested
Tested Applications: IF/IHC: 1:500 ICC: 1:1000 WB: 1:2000
Antigen Retrieval: For an alternative approach, tissue sections could be incubated in 1x Citrate antigen retrieval solution for 30 min at 85°C and cool down to room temperature before next procedure.
Important Notice: MYRF undergoes self-cleavage. This antibody recognizes full-length MYRF and the N-fragment.
Immunogen: N-terminal of mouse MYRF fused to GST.
Purification: Affinity purification
General Notes: FOR RESEARCH USE ONLY
Storage Buffer: pH7.4, PBS, 25mM Tris, 20%~40% Glycerol, 0.1% potassium sorbate
Storage: Shipped at 4°C. Store at 4°C for months and -80°C for years. Avoid freeze/thaw cycle
Background: The myelin regulatory factor gene (MYRF) encodes an evolutionally conserved protein from invertebrates to vertebrates, representing a novel type of membrane-bound transcriptional factors. In vertebrate CNS, MYRF is specifically expressed in differentiating and mature oligodendrocytes and retinal pigment epithelium (RPE) cells, and is also required for their normal development [1, 2]. MYRF is a membrane-bound transcription factor associated with the endoplasmic reticulum (ER) [3, 4]. Upon self-cleavage, the N-fragment of MYRF is released from ER and translocated into nucleus where it functions as a transcription factor. Increasing evidence demonstrates that variants in MYRF are also associated with several human autosomal dominant inheritable disorders, including congenital heart defects (CHD), urogenital anomalies, congenital diaphragmatic hernia (CDH), pulmonary hypoplasia (cardiac-urogenital-diaphragm-lung syndrome; CUDL syndrome, or MYRF-related congenital anomalies syndrome) and nanophthalmos [5-7].
[1] Emery B, et al. Cell. 2009; DIO: 10.1016/j.cell.2009.04.031
[2] Garnai SJ, et al. PLoS Genet. 2019; DIO: 10.1371/journal.pgen.1008130
[3] Bujalka H, et al. PLoS Biol. 2013; DIO: 10.1371/journal.pbio.1001625
[4] Li Z, et al. PLoS Biol. 2013; DIO: 10.1371/journal.pbio.1001624
[5] Rossetti LZ, et al. Am J Med Genet A. 2019; DIO: 10.1002/ajmg.a.61182
[6] Siggs OM, et al. Mol Vis. 2019; PMID: 31700225
[7] Huang H, et al. Neurosci Bull. 2021; DIO: 10.1007/s12264-021-00678-9
[8] Huang H, et al. J Neurosci. 2018; DIO: 10.1523/JNEUROSCI.0154-18.2018
Key Words: oligodendrocyte, myelin, retinal pigment epithelium, RPE, central nervous system, transcriptional factor, endoplasmic reticulum, ER, membrane-bound transcriptional factors, MBTF, Nanophthalmos, CUDL syndrome